Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants
This study has been completed.
Study NCT00831753   Information provided by Sanofi

First Received on January 27, 2009.   Last Updated on January 20, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diphtheria
Tetanus
Pertussis
Haemophilus Influenzae Type B
Hepatitis B
Additional conditions recognized in this trial
Hepatitis
Hepatitis A
Influenza, Human
Tetany
Whooping Cough
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Calcium Metabolism Disorders
Clostridium Infections
Corynebacterium Infections
Digestive System Diseases
DNA Virus Infections
Enterovirus Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Hepadnaviridae Infections
Hepatitis, Viral, Human
Hypocalcemia
Infection
Liver Diseases
Metabolic Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Manifestations
Orthomyxoviridae Infections
Picornaviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Signs and Symptoms
Virus Diseases
Interventions listed in this trial
DTaP IPV HB PRP~T vaccine
Sponsors listed in this trial
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services